RYSTALI
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Mar 2023)
What this means for you
This application is over — abandoned 27 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90892968
- Mark type
- Stylized text
- Filed
- 20 Aug 2021
- Published for opposition
- 28 Jun 2022
- Abandoned
- 27 Mar 2023
- Attorney of record
- Michael A. Geller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of immuno-inflammatory diseases and conditions
Owner
- Aclaris Therapeutics, Inc., Wayne, PA, US
- Aclaris Therapeutics, Inc., Wayne, PA, US
Prosecution history
- 27 Mar 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Mar 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Aug 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jun 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jun 2022 — PUBLISHED FOR OPPOSITION
- 08 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 May 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 May 2022 — EXAMINER'S AMENDMENT ENTERED
- 25 May 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 25 May 2022 — EXAMINERS AMENDMENT E-MAILED
- 25 May 2022 — EXAMINERS AMENDMENT -WRITTEN
- 24 May 2022 — ASSIGNED TO EXAMINER
- 07 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Aug 2021 — NEW APPLICATION ENTERED